Balchem Corporation (BCPC) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Balchem Corporation (BCPC) Materials & Commodity Exposure

Balchem Corporation, a specialty chemicals company, focuses on developing and marketing performance ingredients for human and animal nutrition, along with specialty products for healthcare and industrial applications. With a diverse portfolio and global reach, Balchem serves a wide range of markets through its three key segments.

What Is the Investment Thesis for BCPC?

With a P/E ratio of 32.55 and a profit margin of 15.0%, the company demonstrates solid profitability. Key growth catalysts include expanding its microencapsulation technology and chelated minerals offerings. The company's ability to innovate and adapt to changing market demands, coupled with its established distribution network, positions it for sustained growth. However, potential risks include fluctuations in raw material costs and increased competition in the specialty chemicals market. Investors should monitor the company's ability to maintain its gross margin of 36.3% and dividend yield of 0.60%.

Based on FMP financials and quantitative analysis

BCPC Key Highlights

Market capitalization of $5.36B indicates a strong market presence.

• P/E ratio of 32.55 reflects investor expectations of future earnings growth.
• Profit margin of 15.0% demonstrates efficient operations and pricing strategy.
• Gross margin of 36.3% highlights the company's ability to manage production costs effectively.
• Dividend yield of 0.60% provides a modest income stream for investors.

Who Are BCPC's Competitors?

BCPC is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are BCPC's Key Strengths?

Diversified product portfolio

• Strong market position in specialty ingredients
• Proprietary technologies
• Global distribution network

What Are BCPC's Weaknesses?

Dependence on raw material prices

• Exposure to regulatory changes
• Limited brand recognition compared to larger competitors
• Potential for supply chain disruptions

What Could Drive BCPC Stock Higher?

Continued expansion of microencapsulation technology into new applications.

• Increasing demand for chelated minerals in animal nutrition and high-value crops.
• Potential acquisitions of complementary businesses to expand product offerings.
• Growth in the medical device sterilization market driving demand for ethylene oxide.
• Innovation in human nutrition and health leading to new product development.

What Are the Key Risks for BCPC?

Rich valuation — a P/E of 32.55 runs well above the Basic Materials sector’s ~21.40x, leaving little room for a miss.

• Fluctuations in raw material costs impacting profit margins.
• Increased competition from larger chemical companies.
• Economic downturns affecting demand for specialty ingredients.
• Regulatory changes impacting the use of ethylene oxide in medical device sterilization.
• Supply chain disruptions affecting the availability of key ingredients.

What Are the Growth Opportunities for BCPC?

• Expansion of Microencapsulation Technology: Balchem can further expand its microencapsulation technology across various applications, including pharmaceuticals, food, and animal nutrition. The global microencapsulation market is projected to reach $12.5 billion by 2028, offering significant growth potential. By investing in R&D and strategic partnerships, Balchem can enhance its market share and develop innovative solutions for targeted drug delivery and nutrient release.
• Increased Adoption of Chelated Minerals: The demand for chelated minerals in animal nutrition and high-value crops is increasing due to their enhanced bioavailability and absorption. Balchem can capitalize on this trend by expanding its chelated mineral product line and targeting new markets. The global chelated minerals market is expected to grow at a CAGR of 6.5% from 2021 to 2028, driven by the need for improved animal health and crop yields.
• Growth in Medical Device Sterilization: The Specialty Products segment, which offers ethylene oxide for medical device sterilization, presents a significant growth opportunity. With increasing healthcare regulations and the growing demand for sterilized medical devices, Balchem can expand its market share by providing reliable and efficient sterilization solutions. The global medical device sterilization market is projected to reach $10.5 billion by 2027.
• Strategic Acquisitions and Partnerships: Balchem can pursue strategic acquisitions and partnerships to expand its product portfolio and geographic reach. By acquiring companies with complementary technologies and market access, Balchem can accelerate its growth and strengthen its competitive position. This includes exploring opportunities in emerging markets and expanding its presence in key regions.
• Innovation in Human Nutrition & Health: Balchem can focus on developing innovative ingredients and solutions for the human nutrition and health market, including functional foods, dietary supplements, and personalized nutrition products. By investing in R&D and collaborating with food and beverage companies, Balchem can create value-added products that meet the evolving needs of consumers.

What Are BCPC's Competitive Advantages?

• Specialized product portfolio with niche applications.
• Strong relationships with key customers.
• Proprietary technologies, including microencapsulation and chelation.
• Established distribution network and global reach.

What Does BCPC Do?

Balchem Corporation, founded in 1967 and headquartered in New Hampton, New York, develops, manufactures, and markets specialty performance ingredients and products. The company operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment provides ingredients for the food and beverage industry, including spray dried and emulsified powders, liquid flavor delivery systems, and microencapsulation solutions. This segment also offers human-grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment focuses on enhancing animal health and productivity by providing microencapsulated products and chelation technology for nutrient absorption. The Specialty Products segment offers ethylene oxide for healthcare sterilization and propylene oxide as a fumigant for controlling insects and microbiological spoilage in various food products. Balchem sells its products through a direct sales force, independent distributors, and sales agents, serving the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets globally.

What Products and Services Does BCPC Offer?

• Develops and manufactures specialty performance ingredients.
• Offers solutions for human nutrition and health.
• Provides products for animal nutrition and health.
• Supplies ethylene oxide for medical device sterilization.
• Markets propylene oxide as a fumigant.
• Offers chelated minerals for high-value crops.
• Provides microencapsulation solutions for various applications.

How Does BCPC Make Money?

• Develops and manufactures specialty ingredients and products.
• Sells products through a direct sales force, independent distributors, and sales agents.
• Generates revenue from three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.
• Focuses on innovation and customization to meet specific customer needs.

What Industry Does BCPC Operate In?

Balchem Corporation operates within the specialty chemicals industry, which is characterized by innovation, customization, and a focus on specific applications. The market is driven by increasing demand for performance ingredients in the food, nutrition, and healthcare sectors. Balchem competes with companies like Element Solutions Inc. (ESI), Sasol Limited (SSL), and Axalta Coating Systems Ltd. (AXTA). The industry is experiencing growth due to rising health awareness and the need for advanced sterilization solutions. Balchem's diversified product portfolio and global reach position it well to capitalize on these trends.

Who Are BCPC's Key Customers?

• Food and beverage companies
• Pharmaceutical companies
• Animal feed manufacturers
• Healthcare providers
• Agricultural producers

Wall Street analysts project Balchem Corporation revenue of about $1.13B for fiscal 2026, with EPS near $5.40. The estimate reflects 3 contributing analysts.

Balchem Corporation has beaten Wall Street's EPS estimate in 4 of its last 8 reported quarters — more hits than misses.

Balchem Corporation's Piotroski F-Score is 9/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 10.60 places it in the safe zone, indicating low near-term bankruptcy risk.

Return on equity for Balchem Corporation stands at 12.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 9.3%, showing how much profit it generates from its asset base. BCPC trades at a trailing price-to-earnings ratio of 32.55, above the Basic Materials sector average of ~21.40x. Its free cash flow yield is 3.4%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.55 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 3.0%, the inverse of the P/E and a quick read on earnings relative to price.

Balchem Corporation (BCPC) Valuation Context

Valued at $5.36B, BCPC is classified as a mid-cap stock. Analyst price targets span from $215.00 to $215.00, with a consensus of $215.00. At the current price of $166.67, that implies approximately 29% upside potential. Relative to its peer group, BCPC's quantitative score of 83/100 is roughly in line with the peer average of 74/100.

BCPC Revenue & Earnings Trend

In Jun 2026, BCPC generated $284.0M in top-line revenue, marking a sequential increase of 4.9%. The company recorded net income of $44.6M, with diluted EPS of $1.38. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this mid-cap Basic Materials company. Across the four most recent quarters, BCPC averaged $1.27 in diluted EPS.

Company Profile

Balchem Corporation operates in the Chemicals - Specialty industry within the Basic Materials sector. It is headquartered in Montvale, US. The company is led by CEO Theodore L. Harris. BCPC has traded publicly since 1986.

BCPC Financials

BCPC Latest News

BCPC Analyst Consensus

BCPC MoonshotScore

Common Questions About BCPC (Basic Materials)

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources